Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 4:06 pm Sale | 2020-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | MPM BioVentures IV QP LP | 0 0.000% | -2,242,658 (Position Closed) | Filing History |
| 2021-02-04 10:27 am Purchase | 2020-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | WELLINGTON MANAGEMENT GROUP LLP | 2,615,443 5.540% | 441,220 (+20.29%) | Filing History |
| 2021-02-03 8:14 pm Sale | 2020-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Access Industries Holdings LLC | 2,138,200 4.600% | -890,542 (-29.40%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | BlackRock Inc. BLK | 2,320,406 5.000% | 492,980 (+26.98%) | Filing History |
| 2021-01-20 7:57 pm Sale | 2020-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Domain Partners VIII L.P. | 1,162,554 2.500% | -581,300 (-33.33%) | Filing History |
| 2020-12-10 08:12 am Sale | 2020-11-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX | WELLINGTON MANAGEMENT GROUP LLP | 2,174,223 5.320% | -869,467 (-28.57%) | Filing History |
| 2020-11-04 5:05 pm Purchase | 2020-11-03 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Avidity Partners Management LP | 2,600,000 6.700% | 2,600,000 (New Position) | Filing History |
| 2020-09-09 3:52 pm Purchase | 2020-08-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | BlackRock Inc. BLK | 1,827,426 4.700% | 112,945 (+6.59%) | Filing History |
| 2020-05-11 5:16 pm Purchase | 2020-04-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Boxer Capital LLC | 2,763,569 7.600% | 2,763,569 (New Position) | Filing History |